HK1212384A1 - 用於生產誘導肝細胞的方法和組合物 - Google Patents
用於生產誘導肝細胞的方法和組合物Info
- Publication number
- HK1212384A1 HK1212384A1 HK16100277.6A HK16100277A HK1212384A1 HK 1212384 A1 HK1212384 A1 HK 1212384A1 HK 16100277 A HK16100277 A HK 16100277A HK 1212384 A1 HK1212384 A1 HK 1212384A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- methods
- producing induced
- induced hepatocytes
- hepatocytes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5067—Liver cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/27—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from lung cells, from cells of the respiratory tract
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Developmental Biology & Embryology (AREA)
- Transplantation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261698359P | 2012-09-07 | 2012-09-07 | |
US201361777973P | 2013-03-12 | 2013-03-12 | |
PCT/US2013/058414 WO2014039768A1 (en) | 2012-09-07 | 2013-09-06 | Methods and compositions for producing induced hepatocytes |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1212384A1 true HK1212384A1 (zh) | 2016-06-10 |
Family
ID=49209556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16100277.6A HK1212384A1 (zh) | 2012-09-07 | 2016-01-12 | 用於生產誘導肝細胞的方法和組合物 |
Country Status (15)
Country | Link |
---|---|
US (2) | US20140087416A1 (zh) |
EP (1) | EP2892999A1 (zh) |
JP (1) | JP2015527084A (zh) |
KR (1) | KR20150052228A (zh) |
CN (1) | CN104781393A (zh) |
AU (1) | AU2013312440A1 (zh) |
BR (1) | BR112015005011A2 (zh) |
CA (1) | CA2883714A1 (zh) |
HK (1) | HK1212384A1 (zh) |
IL (1) | IL237433A0 (zh) |
MX (1) | MX2015002917A (zh) |
RU (1) | RU2015107036A (zh) |
SG (1) | SG11201501681SA (zh) |
WO (1) | WO2014039768A1 (zh) |
ZA (1) | ZA201501435B (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9023612B2 (en) | 2012-01-13 | 2015-05-05 | Bell Biosystems, Inc. | Eukaryotic cells with artificial endosymbionts for multimodal detection |
US8956873B2 (en) | 2012-01-13 | 2015-02-17 | Bell Biosystems, Inc. | Host cells with artificial endosymbionts |
US10076579B2 (en) | 2012-01-13 | 2018-09-18 | Bell Biosystems, Inc. | Host cells with artificial endosymbionts |
US8828681B2 (en) | 2012-01-13 | 2014-09-09 | Bell Biosystems, Inc. | Host cells with artificial endosymbionts |
CN103981147B (zh) * | 2013-02-08 | 2017-11-10 | 中国科学院上海生命科学研究院 | 一种新的制备肝实质细胞的方法 |
US9481869B2 (en) | 2013-09-03 | 2016-11-01 | Bell Biosystems, Inc. | Host cell modification with artificial endosymbionts |
CN104830906B (zh) | 2014-02-12 | 2018-09-04 | 北京维通达生物技术有限公司 | 一种重编程获得功能性人肝脏实质细胞的方法 |
US20170107486A1 (en) * | 2014-04-21 | 2017-04-20 | Cellular Dynamics International, Inc. | Hepatocyte production via forward programming by combined genetic and chemical engineering |
CN106572974B (zh) | 2014-07-15 | 2021-04-23 | 生命技术公司 | 用于将分子有效递送到细胞的具有脂质聚集体的组合物和方法 |
WO2016054298A1 (en) * | 2014-10-01 | 2016-04-07 | Bell Biosystems, Inc. | Magnetogenetics |
EP3359169A4 (en) * | 2015-10-05 | 2019-03-13 | Orig3N, Inc. | DIAGNOSIS AND TREATMENT OF MORBUS PARKINSON BASED ON THE IDENTIFICATION AND REDUCTION OF LIVER FUNCTIONAL DISORDERS |
RU2018146815A (ru) * | 2016-06-03 | 2020-07-10 | Стемдженикс, Инк. | Прямое перепрограммировние соматических клеток человека в направлении выбранной (предопределенной) дифференцированной клетки с использованием функционализированных наночпстиц |
US11732240B2 (en) * | 2016-07-28 | 2023-08-22 | Unist (Ulsan National Institute Of Science And Technology) | Direct conversion method of somatic cell into Hepatic stem cell, hepatic cell, or cholangiocyte |
JP2019535272A (ja) * | 2016-11-16 | 2019-12-12 | アリール バイオテクノロジー アンド ファーマシューティカルズ, インコーポレイテッド | Rnaでの幹細胞分化による肝細胞の誘導 |
EP3808380A1 (en) * | 2016-12-08 | 2021-04-21 | CureVac AG | Rna for treatment or prophylaxis of a liver disease |
EP3562845A2 (en) | 2016-12-27 | 2019-11-06 | H. Hoffnabb-La Roche Ag | Novel biotin-specific monoclonal antibody and use thereof |
CN109504650A (zh) * | 2017-09-15 | 2019-03-22 | 海门雨霖细胞科技有限责任公司 | 小分子诱导人成纤维细胞直接重编程为肝细胞的方法 |
EP3702449A4 (en) * | 2017-10-23 | 2021-07-28 | Kyushu University, National University Corporation | METHOD FOR PRODUCING LIVER STEM CELLS OR LIVER ANALYZER CELLS BY DIRECT REPROGRAMMING |
WO2020138208A1 (ja) * | 2018-12-26 | 2020-07-02 | 国立大学法人京都大学 | 肝細胞の製造方法 |
US20220110979A1 (en) * | 2019-01-11 | 2022-04-14 | Figene, Llc | Fibroblast regenerative cells |
EP3931304A4 (en) * | 2019-02-26 | 2022-10-19 | Peking University | COMPOSITIONS AND METHODS FOR REPROGRAMMING NON-HEPATOCYTIC CELLS INTO HEPATOCYTIC CELLS |
CN114085874B (zh) * | 2022-01-10 | 2022-04-29 | 广东乾晖生物科技有限公司 | 一种制备肝功能可逆的永生化肝细胞的方法及其应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2197915B (en) | 1986-11-19 | 1990-11-14 | Rolls Royce Plc | Improvements in or relating to fluid bearings |
US7282366B2 (en) | 2000-04-27 | 2007-10-16 | Geron Corporation | Hepatocytes for therapy and drug screening made from embryonic stem cells |
PL2578685T3 (pl) | 2005-08-23 | 2020-01-31 | The Trustees Of The University Of Pennsylvania | Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania |
US7989204B2 (en) | 2006-04-28 | 2011-08-02 | Viacyte, Inc. | Hepatocyte lineage cells |
US8062632B2 (en) * | 2008-06-23 | 2011-11-22 | National Yang-Ming University | Systems and methods for making hepatocytes from extrahepatic somatic stem cells and use thereof |
EP2510099B1 (en) | 2009-12-07 | 2017-08-09 | The Trustees Of The University Of Pennsylvania | Rna preparations comprising purified modified rna for reprogramming cells |
JPWO2011102532A1 (ja) * | 2010-02-16 | 2013-06-17 | 国立大学法人九州大学 | 誘導肝細胞 |
CA2796251C (en) * | 2010-04-13 | 2019-05-14 | Cellular Dynamics International, Inc. | Hepatocyte production by forward programming |
CN102465115B (zh) * | 2010-11-04 | 2014-03-05 | 中国科学院上海生命科学研究院 | 一种新的制备肝实质细胞的方法 |
CN102286535B (zh) * | 2011-06-17 | 2013-06-05 | 中国人民解放军第二军医大学 | 一种成纤维细胞转分化为肝干细胞的方法 |
-
2013
- 2013-09-06 AU AU2013312440A patent/AU2013312440A1/en not_active Abandoned
- 2013-09-06 CA CA2883714A patent/CA2883714A1/en not_active Abandoned
- 2013-09-06 CN CN201380058024.6A patent/CN104781393A/zh active Pending
- 2013-09-06 SG SG11201501681SA patent/SG11201501681SA/en unknown
- 2013-09-06 MX MX2015002917A patent/MX2015002917A/es unknown
- 2013-09-06 JP JP2015531219A patent/JP2015527084A/ja active Pending
- 2013-09-06 BR BR112015005011A patent/BR112015005011A2/pt not_active IP Right Cessation
- 2013-09-06 US US14/019,677 patent/US20140087416A1/en not_active Abandoned
- 2013-09-06 RU RU2015107036A patent/RU2015107036A/ru not_active Application Discontinuation
- 2013-09-06 EP EP13763162.8A patent/EP2892999A1/en not_active Withdrawn
- 2013-09-06 KR KR1020157008486A patent/KR20150052228A/ko not_active Application Discontinuation
- 2013-09-06 WO PCT/US2013/058414 patent/WO2014039768A1/en active Application Filing
-
2015
- 2015-02-26 IL IL237433A patent/IL237433A0/en unknown
- 2015-03-03 ZA ZA2015/01435A patent/ZA201501435B/en unknown
- 2015-04-02 US US14/677,808 patent/US20150376570A1/en not_active Abandoned
-
2016
- 2016-01-12 HK HK16100277.6A patent/HK1212384A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
IL237433A0 (en) | 2015-04-30 |
AU2013312440A1 (en) | 2015-03-19 |
BR112015005011A2 (pt) | 2018-04-17 |
KR20150052228A (ko) | 2015-05-13 |
SG11201501681SA (en) | 2015-04-29 |
WO2014039768A1 (en) | 2014-03-13 |
CN104781393A (zh) | 2015-07-15 |
JP2015527084A (ja) | 2015-09-17 |
MX2015002917A (es) | 2015-06-03 |
CA2883714A1 (en) | 2014-03-13 |
US20140087416A1 (en) | 2014-03-27 |
RU2015107036A (ru) | 2016-10-27 |
ZA201501435B (en) | 2017-09-27 |
EP2892999A1 (en) | 2015-07-15 |
US20150376570A1 (en) | 2015-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2100012I1 (hu) | 4-Imidazopiridazin-1-il-benzamidok és 4-imidazotriazin-1-il-benzamidok mint BTK-gátlók | |
HK1212384A1 (zh) | 用於生產誘導肝細胞的方法和組合物 | |
IL271305B (en) | Anti-ntb–a antibodies and related compositions and methods | |
EP2836212A4 (en) | NOVEL COMPOSITIONS AND METHOD | |
ZA201408594B (en) | Xylitol-based anti-mucosal compositions and related methods and compositions | |
IL236158A0 (en) | Methods and compositions to create biomethane | |
IL237916A0 (en) | Preparations and methods for preparing glycoproteins | |
HK1206970A1 (zh) | 抗原組合物及方法 | |
GB201315350D0 (en) | Methods and compositions | |
SG11201408326TA (en) | Preparation method for perfluoro-2-methyl-3-pentanone and intermediate | |
GB201315347D0 (en) | Methods and compositions | |
EP2802621A4 (en) | BINDER COMPOSITIONS AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
ZA201308892B (en) | Compositions and methods | |
EP2931280A4 (en) | METHOD AND COMPOSITIONS FOR INHIBITING CNKSR1 | |
EP2852662A4 (en) | HERPESVIRUS COMPOSITIONS AND RELATED METHODS | |
EP2837624A4 (en) | 4-SUBSTITUTE-2-HYDROXYLMORPHOLIN-3-ON AND METHOD OF MANUFACTURING THEREOF | |
EP2766357A4 (en) | MESOBILIVERDINE COMPOSITIONS AND METHOD THEREFOR | |
HK1231520A1 (zh) | 改進的基質穩定性組合物和方法 | |
GB201222820D0 (en) | Woolscouring method and composition | |
GB201206859D0 (en) | Method and composition | |
ZA201500172B (en) | Plant-disease-control composition and plant-disease-control method | |
GB201222736D0 (en) | Composition and process | |
GB201116340D0 (en) | Compositions and methods | |
GB201222810D0 (en) | Woolscouring method and composition | |
GB201204512D0 (en) | Method and composition |